Chi-jen Wu

Ms. Chi-jen Wu

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
CWChi-jen Wu
Chi-jen Wu
THTai-Yang Huang
Tai-Yang Huang
SOSu-Fei Ou
Su-Fei Ou
JSJentaie Shiea
Jentaie Shiea
BLBih-O Lee
Bih-O Lee
Shift work disrupts an otherwise normal circadian rhythm, which may result in sleepiness among night-shift workers. Artificial light has been shown to alter the light–dark cycle of shift workers and reset or phase shift the biological clock, improving nighttime alertness in workers. However, the effect of light therapy on improving sleepiness in nighttime workers has not been effectively confirmed in nursing clinical studies, and it is worth using relevant studies to provide the best evidence in any clinical setting. Systematic review and meta-analysis were used. The study was performed using PRISMA. Academic Search Complete, Embase, MEDLINE, the Cochrane Library, and CINAHL were searched, from the inception of each database to 27 December 2021. The Cochrane risk of bias tool was used to assess the methodological quality of each study. Standardized mean differences (SMDs) with 95% confidence intervals (CIs) were synthesized using a random-effects model to assess the efficacy of lighting intervention to improve sleepiness in night-shift workers. Sensitivity analysis followed by subgroup analysis was employed to examine heterogeneity. The meta-analysis was performed using Review Manager 5.4.1 software. A total of 14 studies from 7 countries were included. The overall result shows that lighting interventions significantly improved sleepiness. Further, the blue-enriched white light with a color temperature greater than 5000 Kelvin was effective in improving sleepiness of night-shift workers. This study unveils the emergent knowledge that light interventions with blue-enriched white were effective in improving sleepiness for night-shift workers, including nurses. This finding can be applied to ensure patient safety, reduce accidents, and improve work efficiency and job satisfaction. Nurses constitute the largest health professional workforce. We suggest that hospitals can insert blue-enriched white light equipment for night-shift healthcare providers. Several evidence-based suggestions are made for further consideration.

Verified
Journal Article
Open access
PDF file
PCPo-Kai Chuang
Po-Kai Chuang
KCKai-Fu Chang
Kai-Fu Chang
CCChih-Hsuan Chang
Chih-Hsuan Chang
TCTing-Yu Chen
Ting-Yu Chen
YWYueh-Jung Wu
Yueh-Jung Wu
TCTung-Yuan Chen
Tung-Yuan Chen
Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide, characterized by high incidence and poor survival rates. Glycosylation, a fundamental post-translational modification, influences protein stability, signaling, and tumor progression, with aberrations implicated in immune evasion and metastasis. This study investigates the role of glycosylation-related genes (Glycosylation-RGs) in CRC using machine learning and bioinformatics. Data from The Cancer Genome Atlas (TCGA) and the Molecular Signatures Database (MSigDB) were analyzed to identify 67 differentially expressed Glycosylation-RGs. These genes were used to classify CRC patients into two subgroups with distinct survival outcomes, highlighting their prognostic value. Weighted gene coexpression network analysis (WGCNA) revealed key modules associated with CRC traits, including pathways like glycan biosynthesis and PI3K–Akt signaling. A machine-learning-based prognostic model demonstrated strong predictive performance, stratifying patients into high- and low-risk groups with significant survival differences. Additionally, the model revealed correlations between risk scores and immune cell infiltration, providing insights into the tumor immune microenvironment. Drug sensitivity analysis identified potential therapeutic agents, including Trametinib, SCH772984, and Oxaliplatin, showing differential efficacy between risk groups. These findings enhance our understanding of glycosylation in CRC, identifying it as a critical factor in disease progression and a promising target for future therapeutic strategies.

20 January 2025 in Annals of Medicine
Verified
Journal Article
Open access
HLHui-Ru Lin
Hui-Ru Lin
YLYungKuo Lee
YungKuo Lee
CCChen-Lin Chang
Chen-Lin Chang
CKChing-Hui Kuo
Ching-Hui Kuo
HHHsin-Yun Ho
Hsin-Yun Ho
CKChou-Yuan Ko
Chou-Yuan Ko
Nurses on the frontlines of the pandemic have increased workloads, burnout, and virus exposure, leading to mental health challenges and a lack of resources for patient care. Mental health support for nurses during the COVID-19 outbreak has become a priority. This study evaluated psychological health outcomes of among nurses during the 2022–2023 COVID-19 pandemic in Taiwan, focusing on personal and work-related fatigue as key contributors to emotional distress. A cross-sectional questionnaire was distributed to 200 nurses in a southern Taiwan hospital between 2022 and 2023. Emotional distress and mental health were assessed using the BSRS-5 (Brief Symptom Rating Scale) and CHQ-12 (Chinese Health Questionnaire). Correlation and regression analyses were conducted to identify factors influencing emotional distress and mental health outcomes. Nurses aged 40–59 (52.85, p = 0.01), those in emergency departments (56.71, p = 0.001), and those caring for COVID-19 patients (50, p = 0.007) reported higher personal exhaustion. Significant differences in work-related fatigue levels were observed based on working environments (52.78, p < 0.001), no beliefs regarding religion (46.53, p = 0.036), care for COVID-19 patients (47, p < 0.001) and previously diagnosed with COVID-19 (46.58, p = 0.005). Key factors influencing emotional distress included marital status, number of children, and workplace (p < 0.05), while mental health variations were noted in age, marital status, number of children, workplace, and years of experience (p < 0.05). During the COVID-19 pandemic, nurses’ emotional distress and mental health were significantly correlated with specific stressors such as age, workplace, care for confirmed COVID-19 patients, and previous COVID-19 diagnoses (p < 0.001). This study highlights the stressors affecting nurses’ mental health during the 2022–2023 COVID-19 pandemic, emphasizing the need for stress-specific mental health support. Understanding these stress-specific factors is important for figuring out what nurses need to improve their mental health, which can lead to better care for patients.

13 January 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
PCPo-Kai Chuang
Po-Kai Chuang
KCKai-Fu Chang
Kai-Fu Chang
CCChih-Hsuan Chang
Chih-Hsuan Chang
TCTing-Yu Chen
Ting-Yu Chen
YWYueh-Jung Wu
Yueh-Jung Wu
TCTung-Yuan Chen
Tung-Yuan Chen
Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide, charac-terized by high incidence and poor survival rates. Glycosylation, a fundamental post-translational modification, influences protein stability, signaling, and tumor pro-gression, with aberrations implicated in immune evasion and metastasis. This study investigates the role of glycosylation-related genes (Glycosylation-RGs) in CRC using machine learning and bioinformatics. Data from The Cancer Genome Atlas (TCGA) and the Molecular Signatures Database (MSigDB) were analyzed to identify 67 differentially expressed Glycosylation-RGs. These genes were used to classify CRC patients into two subgroups with distinct survival outcomes, highlighting their prognostic value. Weighted Gene Coexpression Network Analysis (WGCNA) revealed key modules as-sociated with CRC traits, including pathways like glycan biosynthesis and PI3K-Akt signaling. A machine learning-based prognostic model demonstrated strong predictive performance, stratifying patients into high- and low-risk groups with significant sur-vival differences. Additionally, the model revealed correlations between risk scores and immune cell infiltration, providing insights into the tumor immune microenvironment. Drug sensitivity analysis identified potential therapeutic agents, including Trametinib, SCH772984, and Oxaliplatin, showing differential efficacy between risk groups. These findings enhance our understanding of glycosylation in CRC, identifying it as a critical factor in disease progression and a promising target for future therapeutic strategies.

13 February 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
SCShih-chieh Chen
Shih-chieh Chen
KCKai-Fu Chang
Kai-Fu Chang
CCChien-Cheng Chao
Chien-Cheng Chao
CLChung-Hsien Lin
Chung-Hsien Lin
CCChih-Hsuan Chang
Chih-Hsuan Chang
HLHui-Pu Liu
Hui-Pu Liu
Background Cytokines are central regulators of inflammation and immune responses within the tumor microenvironment and have been implicated in cancer progression and prognosis. However, the prognostic value of coordinated cytokine-related transcriptional programs across cancer types has not been systematically explored. Methods Pan-cancer transcriptomic and clinical data were analyzed to construct a cytokine-related prognostic signature using LASSO Cox regression. Patients were stratified into high-risk and low-risk groups based on the derived risk score. Prognostic performance was evaluated in training and test cohorts, and biological relevance was assessed through survival analyses and pathway-level investigations. Results A 16-gene cytokine-related signature was established that consistently stratified patients into distinct prognostic groups across multiple cancer types. High cytokine-related risk scores were significantly associated with unfavorable survival outcomes and were linked to enhanced cell cycle activity, epithelial-mesenchymal transition, and extracellular matrix remodeling. Integration of the risk score with clinical variables improved individualized survival prediction. Immunohistochemical analyses further confirmed increased protein expression of representative risk-associated genes, including PANX1 and FRMD8, in multiple tumor tissues compared with corresponding normal tissues. Conclusions The cytokine-related prognostic signature captures key inflammatory and immune-related programs underlying tumor aggressiveness and provides a robust tool for pan-cancer risk stratification with potential clinical utility.

Verified
Journal Article
Open access
PDF file
SCShih-chieh Chen
Shih-chieh Chen
KCKai-Fu Chang
Kai-Fu Chang
CCChien-Cheng Chao
Chien-Cheng Chao
CLChung-Hsien Lin
Chung-Hsien Lin
CCChih-Hsuan Chang
Chih-Hsuan Chang
HLHui-Pu Liu
Hui-Pu Liu
Cytokines are central regulators of inflammation and immune responses within the tumor microenvironment and have been implicated in cancer progression and prognosis. However, the prognostic value of coordinated cytokine-related transcriptional programs across cancer types has not been systematically explored. Pan-cancer transcriptomic and clinical data were analyzed to construct a cytokine-related prognostic signature using least absolute shrinkage and selection operator (LASSO) Cox regression. Patients were stratified into high-risk and low-risk groups based on the derived risk score. Prognostic performance was evaluated in training and test cohorts, and biological relevance was assessed through survival analyses and pathway-level investigations. A 16-gene cytokine-related signature was established that consistently stratified patients into distinct prognostic groups across multiple cancer types. High cytokine-related risk scores were significantly associated with unfavorable survival outcomes and were linked to enhanced cell cycle activity, epithelial-mesenchymal transition, and extracellular matrix remodeling. Integration of the risk score with clinical variables improved individualized survival prediction. Immunohistochemical analyses further confirmed increased protein expression of representative risk-associated genes, including pannexin 1 (PANX1) and FERM domain containing 8 (FRMD8), in multiple tumor tissues compared with corresponding normal tissues. The cytokine-related prognostic signature captures key inflammatory and immune-related programs underlying tumor aggressiveness and provides a robust tool for pan-cancer risk stratification with potential clinical utility.